Review highlights nociceptin's involvement in stress modulation in mental illnesses, suggesting therapeutic potential.
The endogenous opioid system, known for its unique role in the complex neurochemical regulation of physiological functions and behavior, is a bright illustration of the concept of the peptide continuum proposed by I.P. Ashmarin [1, 2]. The last of the opioid neuropeptides to be discovered was nociceptin/orphanin (N/OFQ), an endogenous ligand of the nociceptin opioid-like receptor (NOP), which functions are multiple and still not completely clear. In contrast to the active expression of the receptor in various brain regions, N/OFQ expression is more limited and predominantly localized in structures associated with stress and regulation of dopamine neurotransmission. This review presents a current view on the role of N/OFQ and NOP in the modulation of stress and related mental illnesses, including post-traumatic stress disorder. Preclinical data suggest that the use of both NOP agonists and antagonists may represent a promising approach to the treatment of these diseases.
No takes yet. Share an insight, caveat, or question.
Shamakina et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: